E levated blood pressure (BP) is a leading risk factor for morbidity and mortality globally. 1 The substantial public health toll arising from hypertension can be attributed to its high prevalence and associated risk of cardiovascular disease. 2, 3 Although several rare monogenic BP disorders have been identified, mostly involving genes that influence renal sodium handling, 4 the vast majority of hypertension cases result from interactions of multiple genetic and environmental factors.
levated blood pressure (BP) is a leading risk factor for morbidity and mortality globally. 1 The substantial public health toll arising from hypertension can be attributed to its high prevalence and associated risk of cardiovascular disease. 2, 3 Although several rare monogenic BP disorders have been identified, mostly involving genes that influence renal sodium handling, 4 the vast majority of hypertension cases result from interactions of multiple genetic and environmental factors. 5 Numerous genetic loci for the complex BP and hypertension phenotypes have been identified through genome-wide association study (GWAS) meta-analyses. [6] [7] [8] [9] [10] [11] [12] Among environmental factors, dietary sodium and potassium intakes have been established as important determinants of BP. 13, 14 Although BP responses to dietary sodium and potassium intakes are known as moderately heritable phenotypes, 4, [15] [16] [17] the cumulative effects of robustly identified BP loci on salt and potassium sensitivity have never been explored. Associations between BP genetic risk score (GRS) and salt and potassium sensitivity would implicate these phenotypes as mediators on the causal pathway between genomic susceptibility and hypertension, which would add to the observational evidence linking salt sensitivity to this complex condition. 18, 19 Furthermore, identification of a relation between BP GRS and BP salt and potassium sensitivity could eventually identify individuals who might receive enhanced BP-lowering benefits from dietary sodium and potassium interventions and, hence, provide targeted strategies for reducing BP and ultimately preventing hypertension in highrisk subgroups of the population.
The purpose of our study was to examine the relationship between BP GRS, a score comprised loci identified by previous BP GWAS meta-analyses, and BP responses to dietary sodium and potassium intakes. To explore this research question, our study leveraged genome-wide genotype and unique salt-and potassium-sensitivity phenotype data from 1906 Han Chinese participants of a carefully conducted dietary sodium and potassium feeding study.
Methods

Study Population
The GenSalt study (Genetic Epidemiology Network of Salt Sensitivity) is a family feeding study that was conducted from 2003 to 2005 among Han Chinese residents of rural north China. A community-based BP screening was conducted among people aged 18 to 60 years in the study villages to identify potential probands and their families. Detailed eligibility criteria for the probands and siblings/ spouses/offspring have been presented elsewhere. 20 In brief, probands with untreated prehypertension or stage-1 hypertension and their spouses, siblings, and offspring were recruited as volunteers for the dietary intervention study. Those who had stage-2 hypertension, secondary hypertension, a history of clinical cardiovascular disease, or diabetes mellitus, used antihypertensive medications, or were pregnant, heavy alcohol drinkers, or currently on a low-sodium diet were excluded from the study. Among the 1906 eligible participants from 633 families, 1850 (98.4%), 1840 (97.8%), and 1836 (97.6%) participants with GWAS data completed the low-sodium, high-sodium, and potassium-supplementation interventions, respectively, 21 and were included in the current analysis. Institutional review boards or ethnic committees at all participating institutions approved the GenSalt study. Written informed consent was obtained from each GenSalt study participant before baseline data collection and intervention.
Dietary Intervention
The dietary intervention consisted of 3 successive 7-day interventions, including a low-sodium diet (3 g salt or 51.3 mmol sodium/d), a high-sodium diet (18 g salt or 307.8 mmol sodium/d), and a highsodium diet plus potassium supplementation (60 mmol potassium/d). During the period of sodium intervention, dietary potassium intake remained unchanged. Total energy intake was varied according to each participant's baseline energy intake. All study foods were cooked without salt, and prepackaged salt was added to the individual study participant's meal when it was served by the study staff. To ensure study participants' compliance with the intervention program, they were required to have their breakfast, lunch, and dinner at the study kitchen under supervision of the study staff during the entire study period. The study participants were instructed to avoid consuming any foods that were not provided by study personnel. Three timed urinary specimens (one 24-hour and two overnights) were collected at baseline and at the end of each intervention phase (days 5, 6, and 7) to monitor each participant's compliance to the dietary interventions. The overnight urinary excretions of sodium and potassium were converted to 24-hour values based on formulas developed from a random subsample of 238 participants who had collected overnight and 24-hour measures on the same days at baseline and during each phase of intervention.
Phenotype Measurement
A standard questionnaire was administered by trained staff at the baseline examination to collect information on family structure, demographic characteristics, personal and family medical history, and lifestyle risk factors. Body weight and height were also measured twice with participants wearing light indoor clothing without shoes during the baseline examination. Body mass index (BMI) was calculated as kilograms per meters squared (kg/m 2 ). Three BP measurements were recorded at the same time each morning, according to a standard protocol recommended by the American Heart Association, 22 during each of the 3 days of baseline observation, and during days 5, 6, and 7 of each intervention period. All BP measurements were obtained by trained and certified observers using a random zero sphygmomanometer after 5 minutes of rest, with the participants in the sitting position and their arm placed at the level of their heart. Participants were advised to avoid alcohol, cigarette smoking, coffee/ tea, and exercise for at least 30 minutes before their BP measurements. All observers were blinded to the dietary intervention stages.
Salt-sensitivity phenotypes were defined as the absolute changes in systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) when switching from baseline to low-sodium and low-sodium to high-sodium interventions, whereas potassium sensitivity was defined as the absolute changes in SBP, DBP, and MAP when switching from high-sodium to high-sodium plus potassium-supplementation intervention. Mean BP response to low sodium was calculated as the mean of 9 BP measures on days 5, 6, and 7 of the low-sodium intervention minus the mean of 9 BP measures at baseline. Mean BP response to high sodium was calculated as the mean of 9 BP measures on days 5, 6, and 7 of the high-sodium intervention minus the mean of 9 BP measures during the low-sodium intervention. Mean BP response to potassium was calculated as the mean of 9 BP measures on days 5, 6, and 7 of the high-sodium plus potassium intervention minus the mean of 9 BP measures during the high-sodium intervention.
Genotyping, SNP Selection, and GRS
Lymphocyte DNA samples were obtained from study participants. A total of 868 158 autosomal single nucleotide polymorphisms (SNPs) were genotyped using the Affymetrix Genomewide Human SNP array 6.0 (Affymetrix, Inc, Santa Clara, CA). After removal of monomorphic SNPs, SNPs with deviations from Hardy-Weinberg equilibrium (P<1×10 −6 ), missing rate >25%, and a minor allele frequency <1%, 820 017 SNPs remained. The overall non-Mendelian inheritance error rate was 0.019%. Non-Mendelian inheritance errors were identified and corrected using PLINK 23 and PedCheck. 24 We used MiniMac 25, 26 software to impute variants from the 1000 Genomes Phase 3 All Ancestry Panel. Imputation results were summarized as dosage scores (fractional values ranging from 0 to 2, representing the expected number of copies of the coded allele at each SNP).
Variants comprising the GRSs for SBP, DBP, and MAP included those robustly identified in individuals of East Asian ancestry. The GWAS catalogue 27 was searched to identify BP GWAS meta-analyses conducted in at least 10 000 participants of East Asian ancestry in the replication or combined sample. The variants comprising each GRS from the 8 studies identified [6] [7] [8] [28] [29] [30] [31] [32] included independent SNPs (r 2 <0.8) achieving genome-wide significance (P<5×10 −8 ) in the combined sample, and at least nominal significance (P<0.05) and same effect direction in the replication sample. In cases where multiple lead SNPs were reported within 1 linkage disequilibrium block by different studies, the SNP identified by the study with the largest replication sample size was selected. Using effect sizes from the largest replication sample should yield the most precise β-estimate for GRS weighting while avoiding bias attributable to the winner's curse. The 3 GRSs used in this study comprised 43, 42, and 24 independent SNPs for SBP, DBP, and MAP, respectively, with imputation quality r 2 >0.5. In addition, a sensitivity analysis was conducted using all loci identified from previous BP GWAS meta-analyses, [6] [7] [8] [9] [10] [11] [12] [28] [29] [30] [31] [32] [33] [34] [35] regardless of ancestry. These combined ancestry GRSs comprised 94, 93, and 38 independent SNPs for SBP, DBP, and MAP, respectively (Table S1 in the online-only Data Supplement). To limit the analysis to only variants that may influence BP through pathways underlying BP responses to sodium and potassium, another sensitivity analysis was conducted using only loci within 1 Mb of genes previously implicated in BP salt and potassium sensitivity or those thought to influence BP via renal sodium or potassium handling. 4 These pathway restricted GRSs (prGRSs) comprised 9, 7, and 4 independent SNPs for SBP, DBP, and MAP, respectively (Table S6 in the online-only Data Supplement).
Statistical Analysis
Weighted GRSs for SBP, DBP, and MAP were calculated for each participant, as the sum of the products of the participant's dosage score for each SNP and the SNP estimated effect size. Participants were then categorized into quartiles of risk for each GRS.
The means and SDs or frequency and percent of baseline characteristics were calculated for each quartile of the SBP GRS. P values for linear trends in baseline characteristics across quartiles were estimated. A mixed linear regression model was used to assess changes in baseline BP and BP response to each dietary intervention per quartile increase in the categorized GRS and per SD increase in the quantitative GRS. Familial correlations were accounted for using a sandwich estimator and compound symmetry correlation matrix, which assumes the same degree of dependency among family members. All models were adjusted for age, sex, field center, and baseline BMI. The 3 intervention models were also adjusted for baseline BP. Nonlinear trends were assessed by adding a quadratic term to the models. Post hoc analyses were conducted to explore the roles of baseline urinary sodium and potassium excretions on the relation between GRS and BP/BP response phenotypes. All analyses were conducted using SAS software (version 9.3; SAS Institute, Inc, Cary, NC).
Results
Baseline characteristics of GenSalt participants, separated by quartile of SBP GRS, are presented in Table 1 . Genetic burden for elevated BP, represented by SBP GRS, ranged from 24.37 to 54.79. Neither age nor sex was associated with GRS (P=0.12 and 0.11, respectively). Mean BMI ranged from 23.13 in the first quartile to 23.61 in the fourth quartile (P=0.01). As expected, mean baseline SBP increased significantly from 114.51 in the first quartile to 118.58 in the fourth quartile (P=9.9×10 ). Results from 24-hour urinary excretions of sodium and potassium showed excellent compliance to the feeding study (Table S2 in the online-only Data Supplement). Consistent with these findings, SBP, DBP, and MAP decreased significantly when switching from baseline to the low-sodium intervention and from the high-sodium to the potassium intervention, whereas BP values increased significantly when switching from the low-sodium to the high-sodium intervention (all P<0.0001; Figure S1 in the online-only Data Supplement). , and 6.4×10 −6 , respectively), indicating that participants who had higher BP GRS tended to have higher baseline BP (Figure [A] ). In contrast, GRS was inversely associated with the magnitude of BP responses to the low-sodium intervention. Those with higher GRS had significantly smaller decreases in SBP and DBP and marginally smaller decreases in MAP in response to the low-sodium intervention (P=1.4×10 −3 , 0.02, and 0.06, respectively; Figure [B] ). Those with higher GRS also had smaller decreases in SBP in response to the potassium intervention (P=0.05; Figure [D] ). SBP responses to the highsodium intervention and DBP and MAP responses to the high-sodium (Figure [C] ) and potassium ( Figure [D] ) interventions did not significantly differ according to GRS quartile. Results of sensitivity analyses using a combined ancestry GRS, not restricted to loci identified in East Asians, were similar to those of the primary analyses (Table S3 and Figure  S2 in the online-only Data Supplement).
β coefficients, SEs, and P values corresponding to each SD increase in GRS for baseline BP and BP responses to the interventions are shown in Table 2 . As expected, significant positive associations between SBP, DBP, and MAP GRSs and respective baseline SBP, DBP, and MAP levels were identified after adjusting for age, sex, BMI, and field center (P=3.4×10 −9 , 1.9×10 −7 , and 8.0×10 −6 , respectively). Conversely, GRSs for SBP, DBP, and MAP associated with smaller respective SBP (P=3.0×10 −4 ), DBP (P=0.05), and MAP (P=0.05) decreases in response to low-sodium diet after adjusting for age, sex, BMI, field center, and baseline BP. Similarly, SBP GRS associated with smaller increases in SBP in response to high sodium (P=0.04) and high sodium plus potassium supplementation (P=0.04), after multivariable adjustment. No associations between DBP and MAP GRSs and corresponding DBP and MAP responses to the high-sodium and high-sodium plus potassium-supplementation interventions were identified. Furthermore, addition of a quadratic term to models showing significant linear relations did not identify any nonlinear trends (data not shown), and addition of interaction terms for age, sex, and BMI did not identify any significant interactions (data not shown).
Post hoc analyses exploring the role of usual dietary sodium and potassium intakes in the association between BP GRS and BP responses to dietary sodium and potassium were conducted. In univariate analyses, increasing BP GRS marginally positively correlated with habitual dietary sodium and potassium intakes (P=0.06 and 0.06, respectively; Table   Table 1 S4 in the online-only Data Supplement). However, further adjustment for baseline sodium and potassium had no influence on the association between BP GRS and BP responses to the dietary sodium and potassium interventions (Table S5 and Figure S3 in the online-only Data Supplement).
. Characteristics of GenSalt Participants According to SBP GRS Quartile
Additional analyses examining prGRSs, restricted to loci near salt-sensitivity genes, and BP responses to dietary sodium and potassium are presented in Figure S4 and Tables  S6 and S7 in ) decreases in response to low-sodium diet after adjusting for age, sex, BMI, field center, and baseline BP (Table S7 in the online-only Data Supplement). Similar results were obtained when prGRSs comprised loci identified in any population were used (data not shown).
Discussion
In the first study to explore the relationship between BP GRS and BP responses to dietary sodium and potassium, we identified a significant inverse relation between BP GRS and salt and potassium sensitivity of BP. In other words, as the number of BP risk alleles increased BP responses to dietary sodium and potassium intakes tended to decrease. These findings were consistent across BP responses to the low-sodium intervention and SBP responses to high dietary sodium and potassium intakes. Furthermore, results were similar when examining BP GRS according to quartile or as a continuous variable. In contrast, BP GRS was significantly and positively associated with baseline BP levels. Although the direction of association between BP GRS and baseline BP was consistent with our a priori expectation, its inverse relations with the BP response measures were in contrast to our original hypotheses. These data may provide novel implications about the relationship between BP responses to dietary sodium and potassium intakes and BP regulation.
As presumed BP endophenotypes, we hypothesized that those with higher BP GRS would display increased salt and potassium sensitivity compared with those with lower BP GRS. Our finding of an inverse relation between BP GRS and magnitude of BP responses to the dietary interventions was unexpected. Previous studies have suggested that high dietary sodium intake may impair endothelial dependent vasodilation. 36, 37 On the basis of these findings, we speculated that habitual high-sodium intake could blunt endothelium-dependent vasodilation and subsequent BP responses to acute salt depletion and salt loading. In our study, usual dietary sodium intake, defined as baseline urinary sodium excretion, did indeed marginally correlate with BP GRS in post hoc univariate analyses. However, additional adjustment for usual sodium intake had no influence on the observed associations between BP GRS and salt and potassium sensitivity. Thus, our preliminary findings do not support usual sodium intake as a driver of the inverse relation between BP GRS and salt and potassium sensitivity, suggesting that other possible explanations for the observed relationship should be considered. Given recent evidence from GWAS meta-analyses refuting a single dominant effect of renal sodium handling on BP, 8 we also speculated that the observed association of BP GRS with salt resistance may reflect relatively larger influences of BP variants in pathways unrelated to salt and potassium sensitivity when compared with those linked to BP through the BP response endophenotypes. However, analyses restricted to loci near known salt-and potassium-sensitivity genes were consistent with those of our primary analysis and, therefore, do not support this alternate explanation.
Numerous studies have identified salt sensitivity as a risk factor for hypertension. 18, 19, 38 Interestingly, our findings suggest that the relationship between GRS and elevated BP could also be mediated by salt resistance. Although there is a paucity of research exploring whether salt and potassium resistance may associate with altered BP regulation and hypertension phenotypes in humans, animal evidence supports this possibility. 39, 40 Atrial natriuretic peptide, which increases in response to high sodium, has been shown to reduce BP by increasing renal excretion of salt and water, promoting vasodilation, and increasing vascular permeability. [41] [42] [43] Interestingly, mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide had chronically elevated BP that remained unchanged in response to minimal or high-salt diet. 39 Thus, our findings add to the sparse but accumulating literature suggesting a salt-resistant model of hypertension. Future studies that prospectively explore the association between salt resistance and hypertension development in humans are needed to fully articulate this relationship.
As expected, BP GRS was significantly and positively associated with baseline BP. Our finding of SBP and DBP increases of 1.64 and 1.11 mm Hg, respectively, per SD increase in BP GRS was nearly identical to the corresponding increases of 1.65 and 1.06 mm Hg increases in SBP and DBP, respectively, reported previously by Ehret et al. 6 These data strongly suggest that the observed inverse association between BP GRS and salt and potassium sensitivity cannot be attributed to errors in designation and coding of risk alleles. Furthermore, although the associations between BP GRS and baseline BP values were similar using East Asian specific and all ancestry BP GRS, effect sizes per SD increase in GRS were roughly 0.26, 0.13, and 0.10 mm Hg larger for SBP, DBP, and MAP, respectively, using the all ancestry BP GRS. These findings add to the accumulating evidence that variants identified in specific ancestry groups may be relevant to populations with distinct linkage disequilibrium structures.
This study has several strengths. To our knowledge, this is the first study to examine the relationship between BP GRS and salt and potassium sensitivity of BP. The recruitment of all Han Chinese participants who were also similar with respect to lifestyle risk factors such as diet and physical activity should have minimized environmental variation and increased power to detect BP GRS phenotype associations. The response rates to the dietary interventions were high, and compliance, as assessed by urinary excretion of sodium and potassium during each intervention period, was excellent. Measurement error was reduced and power enhanced by the large number of BP measurements that were collected for each participant. Finally, stringent quality control procedures were used during measurement of BP and the other study covariables, conduct of the dietary interventions, genotyping, and marker data cleaning. This study also has several limitations. We hypothesized that habitual sodium intake could have mediated the inverse associations of BP GRS with salt and potassium sensitivity. To explore this hypothesis, we assessed whether the observed association was attenuated when additionally adjusting for baseline urinary sodium excretion values. Because baseline urinary sodium excretion may not accurately represent habitual sodium intake, in part attributable to infradian rhythmic sodium retention and excretion patterns, 44, 45 these findings should be considered preliminary. However, the utilization of urinary sodium excretion measured over 3-day periods should be a more accurate proxy of sodium intake than traditional 24-hour urinary sodium measures. Numerous longitudinal measures of urinary sodium excretion, each measured over multiple days, may be needed to better represent habitual dietary sodium intake and address this research question. In addition, to test whether our findings were consistent, we used a prGRS, which included only variants near genes with known influence on salt and potassium sensitivity or renal electrolyte handling. However, given the strong linkage disequilibrium of variants across regions that frequently include many genes, it is difficult to discern whether all variants in this analysis truly exert their influence through the presumed nearby sodium-or potassium-related gene.
Perspectives
In the first study to explore the association between BP GRS and BP responses to dietary sodium and potassium intakes, we observed an unexpected, inverse relation of BP GRS with salt and potassium sensitivity of BP. As expected, BP GRS was positively and significantly correlated with baseline BP. On the basis of these findings, we cautiously speculate that salt and potassium resistance could act as mediators between genetic background and elevated BP, representing novel markers of future hypertension risk. However, prospective studies are warranted to clearly delineate whether individuals resistant to the typical BP altering effects of dietary sodium and potassium may have an increased risk of hypertension and related cardiovascular disease events.
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